Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...

Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...

Unlike conventional Vitamin D3, which is typically sourced from sheep's wool lanolin, the Thane-based company's VITADEE Green ...

Pharvaris stock jumped early Monday after the FDA agreed to review the company's experimental treatment for a serious ...

A biotech startup and an aerospace startup said their moves to Colorado were based on lifestyle issues and the state’s ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Transparency and intellectual property are crucial when it concerns money being spent towards public interest.

As the nation celebrates its 250th birthday, the most important question is no longer how the United States became the ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Equity Insider News Commentary, The scramble to build a critical-minerals supply chain outside China has become one of the ...